Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study

Zarrelli, 1999, Incidence of epileptic syndromes in Rochester, Minnesota: 1980–1984, Epilepsia, 40, 1708, 10.1111/j.1528-1157.1999.tb01587.x Elixhauser, 1999, The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy, Epilepsy Res, 37, 13, 10.1016/S0920-1211(99)00036-4 Fisher, 2000, The impact of epilepsy from the patient’s perspective: descriptions and subjective perception, Epilepsy Res, 41, 39, 10.1016/S0920-1211(00)00126-1 Paradiso, 2001, Impact of depressed mood on neuropsychological status in temporal lobe epilepsy, J Neurol Neurosurg Psychiatry, 70, 180, 10.1136/jnnp.70.2.180 Hermann, 1995, Executive system dysfunction in temporal lobe epilepsy, J Clin Exp Neuropsychol, 17, 809, 10.1080/01688639508402430 Thomas, 2004, Traitement médical des épilepsies, Neurologie, 1, 390, 10.1016/j.emcn.2004.06.001 Reijs, 2004, Mood effects of antiepileptic drugs, Epilepsy Behav, 5, 66, 10.1016/j.yebeh.2003.11.009 Ortinski, 2004, Cognitive side effects of antiepileptic drugs, Epilepsy Behav, 5, 60, 10.1016/j.yebeh.2003.11.008 Beghi, 2004, Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines, Lancet Neurol, 3, 618, 10.1016/S1474-4422(04)00882-8 Beydoun, 2004, Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy, Neurology, 64, 475, 10.1212/01.WNL.0000150932.48688.BE Sabatowsky, 2004, Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised placebo-controlled clinical trial, Pain, 109, 26, 10.1016/j.pain.2004.01.001 Rickels, 2005, Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam, Arch Gen Psychiatry, 62, 1022, 10.1001/archpsyc.62.9.1022 Pollack, 2005, Pregabalin in generalized anxiety disorder: Influence of subsyndromic depression [abstract], Anxiety Disord Anxiolytics, 3, 55 French, 2001, A systematic review of the safety profile of levetiracetam: a new antiepileptic drug, Epilepsy Res, 47, 77, 10.1016/S0920-1211(01)00296-0 Dinkelacker, 2003, Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy, Epilepsy Behav, 4, 537, 10.1016/j.yebeh.2003.07.008 Smith, 2001, Efficacity of levetiracetam as adjunctive therapy in partial epilepsy [abstract], Epilepsia, 42, 187 Lehrl, 1999 Raven, 1985 Chapuis, 1959 Horn, 1993 Brickenkamp, 2002 Wilson, 1992 Benton Sivan, 1996 Wechsler, 2000 Bronisch, 1994, Comparison of a diagnostic checklist with a structured interview for the assessment of DSM-III-R and ICD-10 personality disorders, Psychopathology, 27, 312, 10.1159/000284889 Derogatis, 1977 Mula, 2002, Levetiracetam and neuropsychiatric adverse events in patients with epilepsy [abstract], Epilepsia, 43, 56 Lamberty, 2003, Anxiolytic profile of the antiepileptic drug levetiracetam in the Vogel conflict test in rat, Eur J Clin Pharmacol, 469, 97, 10.1016/S0014-2999(03)01724-2 Palmer, 2002, Cognitive effects of a levetiracetam add-on therapy in patients with pharmacoresistant focal epilepsy [abstract], Epilepsia, 43, 170 Piazzini, 2002, Levetiracetam: a cognitive study [abstract], Epilepsia, 43, 169 Cramer, 2003, A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials, Epilepsy Behav, 4, 124, 10.1016/S1525-5050(03)00005-2